UCSF

Tagged: Oligonucleotides

Gartner named one of Popular Science’s “Brilliant 10” of 2015

The next frontier in developing therapies for cancer and other diseases could come through studying organ development or tumor growth in living humans. Problem is, there’s no ethical way of doing that using current technology.

Zev Gartner, PhD, has focused on the next best thing: His lab is building fully functioning 3-D human tissue, cell by cell.

Zev Gartner, PhD

Gartner
Professor

My laboratory is working to understand how cells assemble into multicellular tissues, how the structure of tissues controls the behavior of individual cells, and how changes to tissue structure drive the progression of diseases like cancer. Toward these goals, we build, perturb, and model human tissues in vitro using techniques from the chemical, engineering, physical and biological sciences.